A detailed history of Ieq Capital, LLC transactions in Ardelyx, Inc. stock. As of the latest transaction made, Ieq Capital, LLC holds 254,401 shares of ARDX stock, worth $1.49 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
254,401
Previous 196,111 29.72%
Holding current value
$1.49 Million
Previous $768,000 82.81%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

BUY
$3.92 - $6.64 $228,496 - $387,045
58,290 Added 29.72%
254,401 $1.4 Million
Q2 2025

Aug 14, 2025

SELL
$3.28 - $5.51 $58,994 - $99,102
-17,986 Reduced 8.4%
196,111 $768,000
Q1 2025

May 14, 2025

BUY
$4.91 - $6.36 $1.05 Million - $1.36 Million
214,097 New
214,097 $1.05 Million

Others Institutions Holding ARDX

About ARDELYX, INC.


  • Ticker ARDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 154,636,000
  • Market Cap $908M
  • Description
  • Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...
More about ARDX
Track This Portfolio

Track Ieq Capital, LLC Portfolio

Follow Ieq Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ieq Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ieq Capital, LLC with notifications on news.